Loading...
Cet enregistrement a été supprimé. Comme ce document est lié à un enregistrement publié, il est disponible ici à titre de référence uniquement.
Cliquez ici pour consulter l'enregistrement suppriméCe document a été mis à jour. Il ne s’agit pas de la dernière version publiée. Cliquez ici pour voir la dernière version du fichier.
Organisme vivant modifié
(LMO)
L’image ci-dessous identifie l’OVM par son identificateur unique, son nom commercial et un lien vers cette page du Centre d’échange Cliquer dessus pour télécharger une plus grande image sur votre ordinateur Pour du soutien sur comment utiliser, aller dans la page de liens rapides OVM.
Komagataella phaffii strain MXY0541
EN
IF-KPØ541-7
Oui
IF-KPØ541-7
-
Organisation :Impossible Foods Inc. ()Secteur privé (affaires et industrie)400 Saginaw DriveRedwood City, California
94063, États-Unis d'AmériqueTéléphone :Télécopieur :E-mail : regulatory@impossiblefoods.com,Site Web : https://impossiblefoods.com/,
Komagataella phaffii (formerly Pichia pastoris) MXY0541 is a genetically modified strain derived from the parental strain Bg11 (MXY0051) and is an optimized version of the production strain MXY0291 for the production of soybean leghemoglobin by fermentation. To produce soybean leghemoglobin, the strain expresses a codon-optimized lgb2 gene from Glycine max encoding soybean leghemoglobin C2. The optimized strain contains multiple copies of the lgb2 gene to increase soybean leghemoglobin production. To increase intracellular heme availability required for soybean leghemoglobin synthesis, the strain overexpresses the endogenous hem1, hem2, hem3, hem4, hem12, hem13, hem14 and hem15 genes from K. phaffii, which encode the eight enzymes of the heme biosynthesis pathway. The strain also overexpresses a modified MXR1 transcription factor that activates the native AOX1 promoter, thereby enhancing expression of the introduced lgb2 gene and the additional heme biosynthesis genes.
Le terme « organisme récepteur » désigne un organisme (non modifié ou déjà modifié) ayant fait l'objet d'une modification génétique, tandis que les « organismes parentaux » désignent les organismes impliqués dans un croisement ou une fusion cellulaire pour générer un organisme modifié.
-
BCH-ORGA-SCBD-281140-1 Organisme Komagataella phaffii (Yeast, Budding yeast)Champignons
Type of Komagataella phaffii Kurtzman BCCM MUCL 46514 Source: BCCM/MUCL - Agro-food & Environmental Fungal Collection
EN
pMX349 and pMX346 were used to develop the parental strain MXY0291. Portions of these transformation vectors were confirmed by whole genome sequencing of strain MXY0541
EN
- Électroporation
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
Certains de ces éléments génétiques peuvent être présents sous forme de fragments ou sous forme tronquée. Veuillez consulter les notes ci-dessous, s’il y a lieu.
-
BCH-GENE-SCBD-281184-1 Porphobilinogen synthase | Komagataella pastoris (Yeast)Séquence codante de protéines | Utilisation dans les applications industrielles
-
BCH-GENE-SCBD-281177-1 Leghemoglobin C2 | Glycine max (Soybean, Soya bean, Soya / soja /соя, SOYBN)Séquence codante de protéines | Changemetns dans la qualité et/ou la teneur en métabolites
-
BCH-GENE-SCBD-281183-1 Uroporphyrinogen-III (UPG) synthase | Komagataella pastoris (Yeast)Séquence codante de protéines | Utilisation dans les applications industrielles
-
BCH-GENE-SCBD-281185-1 Hydroxymethylbilane synthase | Komagataella pastoris (Yeast)Séquence codante de protéines | Utilisation dans les applications industrielles
-
BCH-GENE-SCBD-281486-1 Uroporphyrinogen-III decarboxylase | Komagataella pastoris (Yeast)Séquence codante de protéines | Utilisation dans les applications industrielles
-
BCH-GENE-SCBD-281487-1 Coproporphyrinogen-III oxidase | Komagataella pastoris (Yeast)Séquence codante de protéines | Utilisation dans les applications industrielles
-
BCH-GENE-SCBD-281485-1 Methanol expression regulator 1 | Komagataella pastoris (Yeast)Séquence codante de protéines | Utilisation dans les applications industrielles
-
BCH-GENE-SCBD-281544-2 Ferrochelatase | Komagataella pastoris (Yeast)Séquence codante de protéines | Utilisation dans les applications industrielles
-
BCH-GENE-SCBD-281476-1 Aminolevulinic acid synthase | Komagataella pastoris (Yeast)Séquence codante de protéines | Utilisation dans les applications industrielles
-
BCH-GENE-SCBD-106441-3 Alcohol oxidase 1 gene promoter | Komagataella pastoris (Yeast)Promoteur
-
BCH-GENE-SCBD-281546-1 Protoporphyrinogen oxidase | Komagataella pastoris (Yeast)Séquence codante de protéines | Utilisation dans les applications industrielles
-
BCH-GENE-SCBD-106442-1 Alcohol oxidase 1 gene terminator | Pichia pastoris (Yeast, PICPA)Terminateur
Information on the inserted DNA sequences
The production strain Komagataella phaffii MXY0541 contains inserted DNA sequences introduced through successive genetic modifications. These comprise expression cassettes for soybean leghemoglobin (lgb2), a modified mxr1 transcription factor, and endogenous heme biosynthesis genes from K. phaffii. The soybean lgb2 coding sequence was codon-optimized for expression in K. phaffii. Publicly available information fully supports the structure of the genetic cassettes 1 and 2. The structures of inserts 3 and 4 were reconstructed from the available molecular characterization, whole-genome sequencing, PCR analyses and application documents, as complete information on their organization and sequence composition has not been publicly disclosed. In addition, PCR analysis and whole-genome sequencing demonstrated that the strain MXY0541 contains several copies of a CPG oxidase cassette and additional copies of the codon-optimized soybean lgb2 gene relative to the intermediate strain MXY0291. Detailed information on the organization, regulatory elements, copy number and genomic insertion sites of these additional inserted DNA sequences has not been publicly disclosed.
The production strain Komagataella phaffii MXY0541 contains inserted DNA sequences introduced through successive genetic modifications. These comprise expression cassettes for soybean leghemoglobin (lgb2), a modified mxr1 transcription factor, and endogenous heme biosynthesis genes from K. phaffii. The soybean lgb2 coding sequence was codon-optimized for expression in K. phaffii. Publicly available information fully supports the structure of the genetic cassettes 1 and 2. The structures of inserts 3 and 4 were reconstructed from the available molecular characterization, whole-genome sequencing, PCR analyses and application documents, as complete information on their organization and sequence composition has not been publicly disclosed. In addition, PCR analysis and whole-genome sequencing demonstrated that the strain MXY0541 contains several copies of a CPG oxidase cassette and additional copies of the codon-optimized soybean lgb2 gene relative to the intermediate strain MXY0291. Detailed information on the organization, regulatory elements, copy number and genomic insertion sites of these additional inserted DNA sequences has not been publicly disclosed.
(1) The codon-optimized soybean lgb2 gene, encoding leghemoglobin C2 from Glycine max, is regulated by the native AOX1 promoter and AOX1 terminator from K. phaffii. Whole-genome sequencing of the intermediate strain MXY0291 identified sixteen copies of this primary expression cassette. High levels of soybean leghemoglobin expression are expected due to the multiple integrated copies of the AOX1-regulated expression cassette.
(2) The modified mxr1 gene is regulated by the native AOX1 promoter and AOX1 terminator from K. phaffii. Due to the cloning strategy, the encoded Mxr1 protein contains six additional amino acids at its N-terminus compared with the native protein. Mxr1 is a transcriptional activator of the AOX1 promoter, resulting in increased expression of the lgb2 gene, the introduced heme biosynthesis genes, and the mxr1 expression cassette itself.
(2) The modified mxr1 gene is regulated by the native AOX1 promoter and AOX1 terminator from K. phaffii. Due to the cloning strategy, the encoded Mxr1 protein contains six additional amino acids at its N-terminus compared with the native protein. Mxr1 is a transcriptional activator of the AOX1 promoter, resulting in increased expression of the lgb2 gene, the introduced heme biosynthesis genes, and the mxr1 expression cassette itself.
(3) Insert 3 contains integrated expression cassettes originally derived from transformation vector pMX349. It comprises expression cassettes for the endogenous hem1, hem3, hem14 and hem15 genes of K. phaffii, encoding four enzymes of the conserved heme biosynthesis pathway. The genes are regulated by additional copies of the native AOX1 promoter and were introduced to increase intracellular heme production required for soybean leghemoglobin synthesis. The order of the expression cassettes and the identity of the terminators have not been publicly disclosed.
(4) Insert 4 contains integrated expression cassettes originally derived from transformation vector pMX346. It comprises expression cassettes for the endogenous hem4, hem2, hem12 and hem13 genes of K. phaffii, encoding four enzymes of the conserved heme biosynthesis pathway. The genes are regulated by additional copies of the native AOX1 promoter and were introduced to increase intracellular heme production required for soybean leghemoglobin synthesis. The hem13 expression cassette is truncated due to incomplete integration. The order of the expression cassettes and the identity of the terminators have not been publicly disclosed.
(4) Insert 4 contains integrated expression cassettes originally derived from transformation vector pMX346. It comprises expression cassettes for the endogenous hem4, hem2, hem12 and hem13 genes of K. phaffii, encoding four enzymes of the conserved heme biosynthesis pathway. The genes are regulated by additional copies of the native AOX1 promoter and were introduced to increase intracellular heme production required for soybean leghemoglobin synthesis. The hem13 expression cassette is truncated due to incomplete integration. The order of the expression cassettes and the identity of the terminators have not been publicly disclosed.
Note
-The strain MXY0541 was developed from the parental strain Bg11 (MXY0051) through a series of sequential genetic modifications, generating the intermediate strains MXY0197, MXY0199, MXY0203, MXY0213, MXY0260 and MXY0291 before the optimized production strain MXY0541 was obtained.
-The intermediate strain MXY0203 was generated by sequential transformation with plasmids pMX349 and pMX346, carrying expression cassettes for the eight endogenous heme biosynthesis genes (hem1, hem2, hem3, hem4, hem12, hem13, hem14 and hem15). Prior to transformation, both plasmids were linearized with the restriction enzyme PmeI, and the expression cassettes were introduced into the recipient strain by electroporation. Antibiotic resistance markers flanked by lox sites were subsequently removed by Cre-lox recombination, resulting in stable chromosomal integration of the expression cassettes under the control of additional copies of the native AOX1 promoter.
-The intermediate strain MXY0260 was generated by co-transformation with a linear pAOX1-MXR1-TAOX1 expression cassette. Transformants were selected using a transient plasmid carrying antibiotic resistance genes, which was subsequently cured and confirmed absent by PCR and antibiotic sensitivity testing.
-The intermediate strain MXY0291 was generated by co-transformation with a linear pAOX1-LGB2-TAOX1 expression cassette. Whole-genome sequencing confirmed that the genome of MXY0291 contains sixteen copies of the pAOX1-lgb2-TAOX1 expression cassette, one mxr1 expression cassette, one partial integration derived from transformation vector pMX349, and two to three partial integrations derived from transformation vector pMX346.These integrated vector-derived sequences contain expression cassettes for the endogenous heme biosynthesis genes but do not contain antibiotic resistance genes or bacterial origins of replication.
-The optimized production strain MXY0541 was generated by introducing additional lgb2 and hem13 sequences to further increase soybean leghemoglobin production. PCR analysis and whole-genome sequencing confirmed the presence of these additional sequences relative to MXY0291. The introduced DNA remained stable over 150–200 generations of growth. Molecular characterization demonstrated the absence of antibiotic resistance genes, functional origins of replication and residual vector backbone sequences in the final production strain. Detailed information on construct design, exact genomic insertion loci, and the complete sequence composition of some inserted DNA sequences has not been made publicly available.
-The strain MXY0541 was developed from the parental strain Bg11 (MXY0051) through a series of sequential genetic modifications, generating the intermediate strains MXY0197, MXY0199, MXY0203, MXY0213, MXY0260 and MXY0291 before the optimized production strain MXY0541 was obtained.
-The intermediate strain MXY0203 was generated by sequential transformation with plasmids pMX349 and pMX346, carrying expression cassettes for the eight endogenous heme biosynthesis genes (hem1, hem2, hem3, hem4, hem12, hem13, hem14 and hem15). Prior to transformation, both plasmids were linearized with the restriction enzyme PmeI, and the expression cassettes were introduced into the recipient strain by electroporation. Antibiotic resistance markers flanked by lox sites were subsequently removed by Cre-lox recombination, resulting in stable chromosomal integration of the expression cassettes under the control of additional copies of the native AOX1 promoter.
-The intermediate strain MXY0260 was generated by co-transformation with a linear pAOX1-MXR1-TAOX1 expression cassette. Transformants were selected using a transient plasmid carrying antibiotic resistance genes, which was subsequently cured and confirmed absent by PCR and antibiotic sensitivity testing.
-The intermediate strain MXY0291 was generated by co-transformation with a linear pAOX1-LGB2-TAOX1 expression cassette. Whole-genome sequencing confirmed that the genome of MXY0291 contains sixteen copies of the pAOX1-lgb2-TAOX1 expression cassette, one mxr1 expression cassette, one partial integration derived from transformation vector pMX349, and two to three partial integrations derived from transformation vector pMX346.These integrated vector-derived sequences contain expression cassettes for the endogenous heme biosynthesis genes but do not contain antibiotic resistance genes or bacterial origins of replication.
-The optimized production strain MXY0541 was generated by introducing additional lgb2 and hem13 sequences to further increase soybean leghemoglobin production. PCR analysis and whole-genome sequencing confirmed the presence of these additional sequences relative to MXY0291. The introduced DNA remained stable over 150–200 generations of growth. Molecular characterization demonstrated the absence of antibiotic resistance genes, functional origins of replication and residual vector backbone sequences in the final production strain. Detailed information on construct design, exact genomic insertion loci, and the complete sequence composition of some inserted DNA sequences has not been made publicly available.
FR
- Nourriture
- EURL-VL-02-21-VM.pdf [ English ]
- IF-KPØ541-7 - EU Reference Laboratory for GM Food and Feed (EURL-GMFF) ( JRC ) [ English ]
FR
The purpose of the genetic modification is the production of soybean leghemoglobin by fermentation. Following fermentation, the yeast cells are lysed and processed to remove insoluble material and concentrate the target protein. The resulting preparation (LegH Prep) contains approximately 9% (w/w) soybean leghemoglobin, residual K. phaffii proteins, and added stabilizers. The product is heat treated to ensure the absence of viable production organisms, although small amounts of residual recombinant K. phaffii DNA (approximately 300 mg/L) may remain. LegH Prep is used as a heme-containing ingredient in plant-based meat products to impart meat-like flavour and aroma.
This record will be updated as additional information becomes publicly available.
This record will be updated as additional information becomes publicly available.
- EFSA document [ English ]
- FSANZ application [ English ]
- Assessment of soy leghemoglobin produced from genetically modified Komagataella phaffii [ English ]
- US10689656.pdf ( patent, expression constructs, methylotrophic, yeast ) [ English ]
- EUginius - MXY0541 Pichia pastoris [ English ]